Current report No. 4/2023 – Cancellation of the managing person

Date: April 12, 2023

Legal basis: Article 17 of the Market Abuse Regulation (MAR) - inside information.

Management Board of Celon Pharma S.A. ("Company") informs that on April 12, 2023, the Supervisory Board of the Company adopted a resolution to dismiss, as of April 12, 2023, Mr. Jacek Glinka from the position of a member of the Management Board (Vice President of the Management Board) of the Company.

The reasons for the cancellation were not disclosed by the Supervisory Board.